Induction of diabetes with streptozotocin (STZ) in different atherosclerosis models, and especially in ApoE−/− mice, has been widely used to study the effects of therapeutic agents or the mechanisms of accelerated atherosclerosis (reviewed in [23]). This evidence concerns the gene APOE and atherosclerosis.